CX3CL1 and cancer: Using a novel ex vivo approach to simultaneously expose NK cells to two key competing tissue compartments in obesity-associated cancer patients, we have shown that blocking CX3CR1 limits fractalkine-mediated NK cell migration towards the soluble chemotactic cues of the omentum but not the tumour.